The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes (T1D). Launched in December 2016, its aim is to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D. It focuses on equity investments in partnership with additional sources of capital, including venture capital, corporations, and foundations. By investing in areas strategically aligned with Breakthrough T1D, it supports innovative approaches and novel mechanisms with curative potential.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions